Skip to Content

Amarantus Bioscience Holdings Inc

Rating as of

Company Profile

Business Description

Amarantus Bioscience Holdings Inc is a United States-based biopharmaceutical company. It is focused on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company's prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia. The group's diagnostics division is dedicated to the development and commercialization of neurology diagnostic products. Its diagnostic product, LymPro Test is a blood-based assay to diagnose Alzheimer's disease.

45 Wall Street, Suite 920
New York, NY, 10005
T +1 650 862-5391
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2018
Fiscal Year End Dec 31, 2018
Stock Type Distressed
Employees 12